BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yan HH, Jiang J, Pang Y, Achyut BR, Lizardo M, Liang X, Hunter K, Khanna C, Hollander C, Yang L. CCL9 Induced by TGFβ Signaling in Myeloid Cells Enhances Tumor Cell Survival in the Premetastatic Organ. Cancer Res. 2015;75:5283-5298. [PMID: 26483204 DOI: 10.1158/0008-5472.CAN-15-2282-T] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Chin AR, Wang SE. Cancer Tills the Premetastatic Field: Mechanistic Basis and Clinical Implications. Clin Cancer Res 2016;22:3725-33. [PMID: 27252414 DOI: 10.1158/1078-0432.CCR-16-0028] [Cited by in Crossref: 51] [Cited by in F6Publishing: 34] [Article Influence: 8.5] [Reference Citation Analysis]
2 吴思凡, 郑琼丹, 崔杰峰. 预转移龛形成--肿瘤转移研究新方向. 世界华人消化杂志 2017; 25(18): 1633-1639 [DOI: 10.11569/wcjd.v25.i18.1633] [Reference Citation Analysis]
3 Bellomo C, Caja L, Moustakas A. Transforming growth factor β as regulator of cancer stemness and metastasis. Br J Cancer 2016;115:761-9. [PMID: 27537386 DOI: 10.1038/bjc.2016.255] [Cited by in Crossref: 107] [Cited by in F6Publishing: 111] [Article Influence: 17.8] [Reference Citation Analysis]
4 Karan D. CCL23 in Balancing the Act of Endoplasmic Reticulum Stress and Antitumor Immunity in Hepatocellular Carcinoma. Front Oncol 2021;11:727583. [PMID: 34671553 DOI: 10.3389/fonc.2021.727583] [Reference Citation Analysis]
5 Wu L, Saxena S, Singh RK. Neutrophils in the Tumor Microenvironment. Adv Exp Med Biol 2020;1224:1-20. [PMID: 32036601 DOI: 10.1007/978-3-030-35723-8_1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
6 Yumoto K, Eber MR, Wang J, Cackowski FC, Decker AM, Lee E, Nobre AR, Aguirre-Ghiso JA, Jung Y, Taichman RS. Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow. Sci Rep 2016;6:36520. [PMID: 27819283 DOI: 10.1038/srep36520] [Cited by in Crossref: 77] [Cited by in F6Publishing: 68] [Article Influence: 12.8] [Reference Citation Analysis]
7 Erkan EP, Ströbel T, Dorfer C, Sonntagbauer M, Weinhäusel A, Saydam N, Saydam O. Circulating Tumor Biomarkers in Meningiomas Reveal a Signature of Equilibrium Between Tumor Growth and Immune Modulation. Front Oncol 2019;9:1031. [PMID: 31649887 DOI: 10.3389/fonc.2019.01031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
8 Ishii H, Vodnala SK, Achyut BR, So JY, Hollander MC, Greten TF, Lal A, Yang L. miR-130a and miR-145 reprogram Gr-1+CD11b+ myeloid cells and inhibit tumor metastasis through improved host immunity. Nat Commun 2018;9:2611. [PMID: 29973593 DOI: 10.1038/s41467-018-05023-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
9 Achyut BR, Arbab AS. Myeloid cell signatures in tumor microenvironment predicts therapeutic response in cancer. Onco Targets Ther 2016;9:1047-55. [PMID: 27042097 DOI: 10.2147/OTT.S102907] [Cited by in Crossref: 9] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
10 Yang L, Hu S, Tan J, Zhang X, Yuan W, Wang Q, Xu L, Liu J, Liu Z, Jia Y, Huang X. Pregnancy-specific glycoprotein 9 (PSG9), a driver for colorectal cancer, enhances angiogenesis via activation of SMAD4. Oncotarget 2016;7:61562-74. [PMID: 27528036 DOI: 10.18632/oncotarget.11146] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
11 Cai C, Long J, Huang Q, Han Y, Peng Y, Guo C, Liu S, Chen Y, Shen E, Long K, Wang X, Yu J, Shen H, Zeng S. M6A "Writer" Gene METTL14: A Favorable Prognostic Biomarker and Correlated With Immune Infiltrates in Rectal Cancer. Front Oncol 2021;11:615296. [PMID: 34221955 DOI: 10.3389/fonc.2021.615296] [Reference Citation Analysis]
12 Krishnan V, Tallapragada S, Schaar B, Kamat K, Chanana AM, Zhang Y, Patel S, Parkash V, Rinker-Schaeffer C, Folkins AK, Rankin EB, Dorigo O. Omental macrophages secrete chemokine ligands that promote ovarian cancer colonization of the omentum via CCR1. Commun Biol 2020;3:524. [PMID: 32963283 DOI: 10.1038/s42003-020-01246-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
13 Jian J, Pang Y, Yan HH, Min Y, Achyut BR, Hollander MC, Lin PC, Liang X, Yang L. Platelet factor 4 is produced by subsets of myeloid cells in premetastatic lung and inhibits tumor metastasis. Oncotarget 2017;8:27725-39. [PMID: 27223426 DOI: 10.18632/oncotarget.9486] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
14 Stefanescu C, Van Gogh M, Roblek M, Heikenwalder M, Borsig L. TGFβ Signaling in Myeloid Cells Promotes Lung and Liver Metastasis Through Different Mechanisms. Front Oncol 2021;11:765151. [PMID: 34868988 DOI: 10.3389/fonc.2021.765151] [Reference Citation Analysis]
15 Singh S, Zhang XHF, Rosen JM. TIME Is a Great Healer-Targeting Myeloid Cells in the Tumor Immune Microenvironment to Improve Triple-Negative Breast Cancer Outcomes. Cells 2020;10:E11. [PMID: 33374595 DOI: 10.3390/cells10010011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Li S, Dong Y, Wang K, Wang Z, Zhang X. Transcriptomic analyses reveal the underlying pro-malignant functions of PTHR1 for osteosarcoma via activation of Wnt and angiogenesis pathways. J Orthop Surg Res 2017;12:168. [PMID: 29121993 DOI: 10.1186/s13018-017-0664-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
17 Zhang J, Späth SS, Weissman SM, Katz SG. An Overview of Advances in Cell-Based Cancer Immunotherapies Based on the Multiple Immune-Cancer Cell Interactions. Methods Mol Biol 2020;2097:139-71. [PMID: 31776925 DOI: 10.1007/978-1-0716-0203-4_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Trappetti V, Fazzari JM, Fernandez-Palomo C, Scheidegger M, Volarevic V, Martin OA, Djonov VG. Microbeam Radiotherapy-A Novel Therapeutic Approach to Overcome Radioresistance and Enhance Anti-Tumour Response in Melanoma. Int J Mol Sci 2021;22:7755. [PMID: 34299373 DOI: 10.3390/ijms22147755] [Reference Citation Analysis]
19 Wu L, Saxena S, Awaji M, Singh RK. Tumor-Associated Neutrophils in Cancer: Going Pro. Cancers (Basel) 2019;11:E564. [PMID: 31010242 DOI: 10.3390/cancers11040564] [Cited by in Crossref: 96] [Cited by in F6Publishing: 90] [Article Influence: 32.0] [Reference Citation Analysis]
20 Kim HR, Park SM, Seo SU, Jung I, Yoon HI, Gabrilovich DI, Cho BC, Seong SY, Ha SJ, Youn JI. The Ratio of Peripheral Regulatory T Cells to Lox-1+ Polymorphonuclear Myeloid-derived Suppressor Cells Predicts the Early Response to Anti-PD-1 Therapy in Patients with Non-Small Cell Lung Cancer. Am J Respir Crit Care Med 2019;199:243-6. [PMID: 30339766 DOI: 10.1164/rccm.201808-1502LE] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 11.3] [Reference Citation Analysis]
21 Ang AD, Vissers MCM, Burgess ER, Currie MJ, Dachs GU. Gene and Protein Expression Is Altered by Ascorbate Availability in Murine Macrophages Cultured under Tumour-Like Conditions. Antioxidants (Basel) 2021;10:430. [PMID: 33799728 DOI: 10.3390/antiox10030430] [Reference Citation Analysis]
22 Li F, Du X, Lan F, Li N, Zhang C, Zhu C, Wang X, He Y, Shao Z, Chen H, Luo M, Li W, Chen Z, Ying S, Shen H. Eosinophilic inflammation promotes CCL6-dependent metastatic tumor growth. Sci Adv 2021;7:eabb5943. [PMID: 34039594 DOI: 10.1126/sciadv.abb5943] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Kang Y, Jin Y, Li Q, Yuan X. Advances in Lung Cancer Driver Genes Associated With Brain Metastasis. Front Oncol 2020;10:606300. [PMID: 33537237 DOI: 10.3389/fonc.2020.606300] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Mitsui Y, Tomonobu N, Watanabe M, Kinoshita R, Sumardika IW, Youyi C, Murata H, Yamamoto KI, Sadahira T, Rodrigo AGH, Takamatsu H, Araki K, Yamauchi A, Yamamura M, Fujiwara H, Inoue Y, Futami J, Saito K, Iioka H, Kondo E, Nishibori M, Toyooka S, Yamamoto Y, Nasu Y, Sakaguchi M. Upregulation of Mobility in Pancreatic Cancer Cells by Secreted S100A11 Through Activation of Surrounding Fibroblasts. Oncol Res 2019;27:945-56. [PMID: 31046874 DOI: 10.3727/096504019X15555408784978] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
25 Zhang D, Rennhack J, Andrechek ER, Rockwell CE, Liby KT. Identification of an Unfavorable Immune Signature in Advanced Lung Tumors from Nrf2-Deficient Mice. Antioxid Redox Signal 2018;29:1535-52. [PMID: 29634345 DOI: 10.1089/ars.2017.7201] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
26 Crespo Yanguas S, da Silva TC, Pereira IVA, Maes M, Willebrords J, Shestopalov VI, Goes BM, Sayuri Nogueira M, Alves de Castro I, Romualdo GR, Barbisan LF, Gijbels E, Vinken M, Cogliati B. Genetic ablation of pannexin1 counteracts liver fibrosis in a chemical, but not in a surgical mouse model. Arch Toxicol 2018;92:2607-27. [PMID: 29987408 DOI: 10.1007/s00204-018-2255-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
27 Gao Y, Lin P, Lydon JP, Li Q. Conditional abrogation of transforming growth factor-β receptor 1 in PTEN-inactivated endometrium promotes endometrial cancer progression in mice. J Pathol 2017;243:89-99. [PMID: 28657664 DOI: 10.1002/path.4930] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
28 Wang Y, Ding Y, Guo N, Wang S. MDSCs: Key Criminals of Tumor Pre-metastatic Niche Formation. Front Immunol 2019;10:172. [PMID: 30792719 DOI: 10.3389/fimmu.2019.00172] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 19.3] [Reference Citation Analysis]
29 López de Andrés J, Griñán-Lisón C, Jiménez G, Marchal JA. Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment. J Hematol Oncol 2020;13:136. [PMID: 33059744 DOI: 10.1186/s13045-020-00966-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
30 Yang L, Lin PC. Mechanisms that drive inflammatory tumor microenvironment, tumor heterogeneity, and metastatic progression. Semin Cancer Biol 2017;47:185-95. [PMID: 28782608 DOI: 10.1016/j.semcancer.2017.08.001] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 11.4] [Reference Citation Analysis]
31 Sharma T, Cotney J, Singh V, Sanjay A, Reichenberger EJ, Ueki Y, Maye P. Investigating global gene expression changes in a murine model of cherubism. Bone 2020;135:115315. [PMID: 32165349 DOI: 10.1016/j.bone.2020.115315] [Reference Citation Analysis]
32 Jinushi M, Morita T, Xu Z, Kinoshita I, Dosaka-Akita H, Yagita H, Kawakami Y. Autophagy-dependent regulation of tumor metastasis by myeloid cells. PLoS One 2017;12:e0179357. [PMID: 28686632 DOI: 10.1371/journal.pone.0179357] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
33 Li S, Liu F, Pei Y, Dong Y, Shang Y. Parathyroid hormone type 1 receptor regulates osteosarcoma K7M2 Cell growth by interacting with angiotensinogen. J Cell Mol Med 2021;25:2841-50. [PMID: 33511766 DOI: 10.1111/jcmm.16314] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]